Literature DB >> 16707778

Defining and assessing adherence to oral antipsychotics: a review of the literature.

Dawn I Velligan1, Yui-Wing Francis Lam, David C Glahn, Jennifer A Barrett, Natalie J Maples, Larry Ereshefsky, Alexander L Miller.   

Abstract

The definition and assessment of adherence vary considerably across studies. Increasing consensus regarding these issues is necessary to improve our understanding of adherence and the development of more effective treatments. We review the adherence literature over the past 3 decades to explore the definitions and assessment of adherence to oral antipsychotics in schizophrenia patients. A total of 161 articles were identified through MEDLINE and PsycINFO searches. The most common method used to assess adherence was the report of the patient. Subjective and indirect methods including self-report, provider report, significant other report, and chart review were the only methods used to assess adherence in over 77% (124/161) of studies reviewed. Direct or objective measures including pill count, blood or urine analysis, electronic monitoring, and electronic refill records were used in less than 23% (37/161) of studies. Even in studies utilizing the same methodology to assess adherence, definitions of an adherent subject varied broadly from agreeing to take any medication to taking at least 90% of medication as prescribed. We make suggestions for consensus development, including the use of recommended terminology for different subject samples, the increased use of objective or direct measures, and the inclusion in all studies of an estimate of the percentage of medication taken as prescribed in an effort to increase comparability among studies. The suggestions are designed to advance the field with respect to both understanding predictors of adherence and developing interventions to improve adherence to oral antipsychotic medications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707778      PMCID: PMC2632258          DOI: 10.1093/schbul/sbj075

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  161 in total

1.  Examining adherence to medication and substance use as possible confounds of duration of untreated psychosis.

Authors:  Ross M G Norman; Ashok K Malla
Journal:  J Nerv Ment Dis       Date:  2002-05       Impact factor: 2.254

2.  The capacity of a measure of disability (the LSP) to predict hospital readmission in those with schizophrenia.

Authors:  G Parker; D Hadzi-Pavlovic
Journal:  Psychol Med       Date:  1995-01       Impact factor: 7.723

3.  Reasons for admission among six profile subgroups of recidivists of inpatient services.

Authors:  E S Casper; J R Regan
Journal:  Can J Psychiatry       Date:  1993-12       Impact factor: 4.356

4.  Rating of medication influences (ROMI) scale in schizophrenia.

Authors:  P Weiden; B Rapkin; T Mott; A Zygmunt; D Goldman; M Horvitz-Lennon; A Frances
Journal:  Schizophr Bull       Date:  1994       Impact factor: 9.306

5.  Predicting medication compliance in a psychotic population.

Authors:  S G Adams; J T Howe
Journal:  J Nerv Ment Dis       Date:  1993-09       Impact factor: 2.254

6.  A community ability scale for chronically mentally ill consumers: Part I. Reliability and validity.

Authors:  S Barker; N Barron; B H McFarland; D A Bigelow
Journal:  Community Ment Health J       Date:  1994-08

7.  Family-based intervention for schizophrenic patients in China. A randomised controlled trial.

Authors:  W Xiong; M R Phillips; X Hu; R Wang; Q Dai; J Kleinman; A Kleinman
Journal:  Br J Psychiatry       Date:  1994-08       Impact factor: 9.319

8.  Age and other factors relevant to the rehospitalization of schizophrenic outpatients.

Authors:  H Hoffmann
Journal:  Acta Psychiatr Scand       Date:  1994-03       Impact factor: 6.392

9.  Demographic factors associated with extreme non-compliance in schizophrenia.

Authors:  W Sellwood; N Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-07       Impact factor: 4.328

10.  Multiple-family groups and psychoeducation in the treatment of schizophrenia.

Authors:  W R McFarlane; E Lukens; B Link; R Dushay; S A Deakins; M Newmark; E J Dunne; B Horen; J Toran
Journal:  Arch Gen Psychiatry       Date:  1995-08
View more
  74 in total

Review 1.  Self-report measures of medication adherence behavior: recommendations on optimal use.

Authors:  Michael J Stirratt; Jacqueline Dunbar-Jacob; Heidi M Crane; Jane M Simoni; Susan Czajkowski; Marisa E Hilliard; James E Aikens; Christine M Hunter; Dawn I Velligan; Kristen Huntley; Gbenga Ogedegbe; Cynthia S Rand; Eleanor Schron; Wendy J Nilsen
Journal:  Transl Behav Med       Date:  2015-07-09       Impact factor: 3.046

2.  New paradigms for treatment development.

Authors:  Ellen L Stover; Linda Brady; Stephen R Marder
Journal:  Schizophr Bull       Date:  2007-08-02       Impact factor: 9.306

3.  A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine.

Authors:  Paul A Nakonezny; Carroll W Hughes; Taryn L Mayes; Kathryn H Sternweis-Yang; Betsy D Kennard; Matthew J Byerly; Graham J Emslie
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-10       Impact factor: 2.576

4.  Expressed emotion and sociocultural moderation in the course of schizophrenia.

Authors:  Adrian Aguilera; Steven R López; Nicholas J K Breitborde; Alex Kopelowicz; Roberto Zarate
Journal:  J Abnorm Psychol       Date:  2010-11

5.  The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia.

Authors:  Dawn I Velligan; Pamela M Diamond; Jim Mintz; Natalie Maples; Xueying Li; John Zeber; Larry Ereshefsky; Yui-Wing F Lam; Desiree Castillo; Alexander L Miller
Journal:  Schizophr Bull       Date:  2007-10-10       Impact factor: 9.306

Review 6.  Tactics and technologies to manage nonadherence in patients with schizophrenia.

Authors:  William M Glazer; Mathew J Byerly
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

Review 7.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

8.  Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimens.

Authors:  Dyfrig A Hughes
Journal:  Br J Clin Pharmacol       Date:  2008-04-01       Impact factor: 4.335

Review 9.  Guidelines for the Pharmacotherapy of Schizophrenia in Adults.

Authors:  Gary Remington; Donald Addington; William Honer; Zahinoor Ismail; Thomas Raedler; Michael Teehan
Journal:  Can J Psychiatry       Date:  2017-07-13       Impact factor: 4.356

Review 10.  Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review.

Authors:  Nicole M Lanouette; David P Folsom; Andres Sciolla; Dilip V Jeste
Journal:  Psychiatr Serv       Date:  2009-02       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.